After the genome of HeLa cancer cell line was published earlier this month, researchers like Jonathan Eisen at The Tree of Life noticed that the Lacks family did not appear to give its consent to have the genome published. This, adds Peter Lipson at Forbes, is a "double ethical lapse."
Registering provides access to this and other free content.
Already have an account?Login Now.
In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.
The new Riken president outlines some of his plans for the institute.
The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.
An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.